IGF1 and cardiovascular disorder: Despite GALNT16 being classified as an N‐acetylgalactosaminyltransferase, previous studies have implicated it in protein and lipid metabolism, as well as in AMPK, prolactin, and insulin/IGF signaling pathways, and it may also play a role in lipid metabolism associated with cardiovascular diseases.